Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for guanabenz (compound)
Most Correlated Studies
- Multiple myeloma RPMI8226 cells treated with eIF2a phosphatase inhibitors, Guanabenz and Sal003
- Drug target sets for approved compounds
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Most Relevant Literature
- Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
- Guanabenz-an old drug with a potential to decrease obesity.
- Guanabenz ameliorates disease in vanishing white matter mice in contrast to sephin1.
- Geometric Isomer of Guanabenz Confers Hepatoprotection to a Murine Model of Acetaminophen Toxicity.
- Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis.
Most Relevant Clinical Trials
- Oral Guanabenz for Multiple Sclerosis
- Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
- Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease
- Longitudinal Investigation of I2BS in PD
- A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Adm…
